There’s little on the web about Quercegen Pharma, based in Newton, MA, however yesterday, Appalachian State University (Boone, NC) announced reception of a $1.027 million grant by Quercegen Pharma to continue their research of the health benefits of quercetin. If you are in the Boone, NC area: to participate in the study, e-mail asuresearch@appstate.edu
This is the largest one-year research grant awarded to the university and will involve the largest number of test subjects—1,000 participants over the next year.
The American Cancer Society writes that there is no reliable clinical evidence that quercetin can prevent or treat cancer in humans. However, with the large study beginning now, valuable science may be forthcoming.
Earlier this month, quercetin was a component found in one of these three prostate-specific dietary supplements: Trinovin, Provelex and ProstateRx, which were under scrutiny by American Society for Therapeutic Radiology and Oncology (ASTRO). Researchers determined these products were problematic for patients being treated for prostate cancer with radiation. The warning was to avoid use of the supplements during radiation treatment. This information was reported by Doctor’s Guide. View the 2 hour lecture sets yourself!
Again from the ACS: Quercetin is a common chemical pigment in the rinds and barks of a wide variety of plants. It is one of the main flavonoids in the diet, and is found in large amounts in apple skins, onions, teas, and red wines. It is also found in leafy green vegetables, berries, and in herbs such as ginkgo and St. John’s wort.